Belle Mead, NJ, United States of America

James Kowalski

This inventor holds 1 USPTO granted patent and 12 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignee: Novartis Ag. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Kowalski. Retrieved from https://idiyas.com/inventor/james-kowalski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: James Kowalski: Innovator in Pharmaceutical Formulation

Introduction

James Kowalski is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of pharmaceutical formulations. His work focuses on processes for creating solid dispersions of pharmaceutical active ingredients.

Latest Patents

James Kowalski holds 1 patent related to pharmaceutical formulation. This patent provides innovative processes for making and forms of solid dispersions, which are crucial for enhancing the solubility and bioavailability of drugs.

Career Highlights

Throughout his career, Kowalski has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has allowed him to develop and refine his expertise in pharmaceutical formulations.

Collaborations

James Kowalski has collaborated with talented professionals in his field, including Rama Ali Abu Shmeis and Steven L. Krill. These collaborations have contributed to the advancement of his work and the successful development of innovative pharmaceutical solutions.

Conclusion

James Kowalski is a dedicated inventor whose work in pharmaceutical formulations has made a significant impact on the industry. His innovative approaches continue to influence the development of effective drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…